Vivian Huang

Safety and efficacy of ozanimod versus interferon beta-1a in relapsing multiple sclerosis (RADIANCE): a multicentre, randomised, 24-month, phase 3 trial

Jeffrey A. Cohen, Krzysztof Selmaj, Amit Bar‐Or et al. · The Lancet Neurology · 2019 · 279 citations

Life Sciences, Neurology, Pharmacotherapy +8

Substantial prevalence of microdeletions of the Y-chromosome in infertile men with idiopathic azoospermia and oligozoospermia detected using a sequence-tagged site-based mapping strategy.

Hossein Najmabadi, Vivian Huang, P. H. Yen et al. · The Journal of Clinical Endocrinology & Metabolism · 1996 · 193 citations

Medicine, Genetics, Molecular Genetics +14

Clinical, endoscopic and radiographic outcomes with ustekinumab in medically‐refractory Crohn's disease: real world experience from a multicentre cohort

Christopher Ma, Richard N. Fedorak, Gilaad G. Kaplan et al. · Alimentary Pharmacology & Therapeutics · 2017 · 185 citations · Full text

Veterinary Medicine, Clinical Sciences, Immunology +17

Long-term Maintenance of Clinical, Endoscopic, and Radiographic Response to Ustekinumab in Moderate-to-Severe Crohnʼs Disease

Christopher Ma, Richard N. Fedorak, Gilaad G. Kaplan et al. · Inflammatory Bowel Diseases · 2017 · 121 citations · Full text

Medicine, Clinical Sciences, Immunology +17

Long-Term Efficacy and Safety of Ozanimod in Moderately to Severely Active Ulcerative Colitis: Results From the Open-Label Extension of the Randomized, Phase 2 TOUCHSTONE Study

William J. Sandborn, Brian G. Feagan, Stephen B. Hanauer et al. · Journal of Crohn s and Colitis · 2021 · 106 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +14